Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.950
-0.320 (-7.49%)
At close: Apr 28, 2026, 4:00 PM EDT
3.930
-0.020 (-0.51%)
After-hours: Apr 28, 2026, 8:00 PM EDT
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Perspective Therapeutics stock have an average target of 12.11, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 206.58% from the current stock price of 3.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Perspective Therapeutics stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 3 | 3 | 3 | 4 | 3 | 3 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +178.48% | Apr 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +229.11% | Mar 23, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $13 | Strong Buy | Maintains | $11 → $13 | +229.11% | Mar 18, 2026 |
| UBS | UBS | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +102.53% | Mar 18, 2026 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +178.48% | Mar 18, 2026 |
Financial Forecast
Revenue This Year
627.43K
from 884.00K
Decreased by -29.02%
Revenue Next Year
441.66K
from 627.43K
Decreased by -29.61%
EPS This Year
-1.15
from -1.40
EPS Next Year
-1.11
from -1.15
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.5M | 1.3M | ||||||
| Avg | 627,433 | 441,660 | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 66.3% | 112.6% | ||||||
| Avg | -29.0% | -29.6% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.96 | -0.88 | ||||||
| Avg | -1.15 | -1.11 | ||||||
| Low | -1.54 | -1.45 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.